Troyen A Brennan
CIK 1351402 · EVP and Chief Medical Officer · last filed 2022-04-05
Troyen A Brennan is an EVP and Chief Medical Officer who has filed 50 SEC Form 4 insider transactions across 1 company since 2008. The most recent filing shows the insider had shares withheld for taxes covering $8.1M of CVS on Apr 5, 2022. Across all open-market trades the lifetime net is −$66.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $25.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$25.40M
1
50
-$66.35M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CVS | EVP and Chief Medical Officer | 234,855 | $108.17 | $25.40M | -$66.35M | 46 | 2022-04-05 |
Recent Filings
50 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-05 | CVS | Tax (F) | −80,139 | -$8.10M | EDGAR |
| 2022-02-23 | CVS | Grant (A) | +171,944 | $0 | EDGAR |
| 2022-02-04 | CVS | Mixed | — | -$371.0K | EDGAR |
| 2021-11-03 | CVS | Mixed | — | -$891.5K | EDGAR |
| 2021-10-28 | CVS | Mixed | −1,955 | -$2.90M | EDGAR |
| 2021-09-07 | CVS | Sell (S) | −2,625 | -$228.4K | EDGAR |
| 2021-06-17 | CVS | Mixed | −1,871 | -$1.72M | EDGAR |
| 2021-05-10 | CVS | Sell (S) | −9,477 | -$796.1K | EDGAR |
| 2021-04-02 | CVS | Mixed | +50,038 | -$3.30M | EDGAR |
| 2021-01-12 | CVS | Mixed | −4,346 | -$364.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.